Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
全球貨幣，賓夕法尼亞州韋恩，2024年9月10日（全球新聞社）- Aclaris Therapeutics, Inc.（納斯達克：ACRS）是一家臨床階段的生物製藥公司，專注於開發新型藥物候選品，用於免疫炎症性疾病。今天宣佈，Aclaris管理團隊的成員將參加2024年康泰爾全球醫療保健會議期間的座談會，時間爲2024年9月17日上午8:00 Et，在紐約。
A webcast of the fireside chat may be accessed through the "Events" page of the "Investors" section of Aclaris' website, . The webcast will be archived for at least 30 days on the Aclaris website.
通過Aclaris官網的「投資者」版塊的「活動」頁面，可以訪問座談會的網絡直播。該網絡直播將在Aclaris官網存檔至少30天。
About Aclaris Therapeutics, Inc.
關於Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .
Aclaris Therapeutics, Inc.是一家臨床階段的生物製藥公司，致力於開發一系列新型藥物候選品，以滿足免疫炎症性疾病患者的需求，這些患者缺乏滿意的治療選擇。該公司擁有一個多階段的藥物候選品組合，由強大的研發引擎驅動，探索蛋白激酶調控。更多信息請訪問。
Aclaris Therapeutics Contact:
Aclaris Therapeutics 聯繫方式：
investors@aclaristx.com
investors@aclaristx.com
